Status:
TERMINATED
Dosing of Ketorolac in the Emergency Department
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Acute Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The optimal dose of ketorolac in the Emergency Department setting is no clear. We will compare 3 doses to determine the optimal dose.
Detailed Description
Patients from 4 groups will be treated with 3 different doses of ketorolac. The groups are 1. headache 2. abdominal pain 3. musculo-skeletal pain 4. viral syndrome. The doses will be 0, 10, 30mgs of k...
Eligibility Criteria
Inclusion
- \> 18 y/o
Exclusion
- pregnant allergic other contraindication
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
289 Patients enrolled
Trial Details
Trial ID
NCT03464461
Start Date
May 1 2018
End Date
May 30 2024
Last Update
November 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri Health Care
Columbia, Missouri, United States, 65212